MediPharm Labs (MediPharm Labs) EV-to-EBIT : -1.29 (As of Jun. 24, 2024)

View and export this data going back to 2018. Start your Free Trial

What is MediPharm Labs EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, MediPharm Labs's Enterprise Value is $12.84 Mil. MediPharm Labs's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-9.97 Mil. Therefore, MediPharm Labs's EV-to-EBIT for today is -1.29.

The historical rank and industry rank for MediPharm Labs's EV-to-EBIT or its related term are showing as below:

MEDIF' s EV-to-EBIT Range Over the Past 10 Years
Min: -2809.8 Med: -0.85 Max: 161.97
Current: -1.29

During the past 7 years, the highest EV-to-EBIT of MediPharm Labs was 161.97. The lowest was -2809.80. And the median was -0.85.

MEDIF's EV-to-EBIT is ranked worse than
100% of 669 companies
in the Drug Manufacturers industry
Industry Median: 16.83 vs MEDIF: -1.29

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. MediPharm Labs's Enterprise Value for the quarter that ended in Mar. 2024 was $14.59 Mil. MediPharm Labs's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was $-9.97 Mil. MediPharm Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 was -68.28%.

MediPharm Labs EV-to-EBIT Historical Data

The historical data trend for MediPharm Labs's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MediPharm Labs EV-to-EBIT Chart

MediPharm Labs Annual Data

Trend

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

66.69

-1.26

-0.38

0.13

-0.80

MediPharm Labs Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-EBIT	Get a 7-Day Free Trial															0.01	-0.52	-1.28	-0.80	-1.31

Competitive Comparison of MediPharm Labs's EV-to-EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, MediPharm Labs's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MediPharm Labs's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, MediPharm Labs's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where MediPharm Labs's EV-to-EBIT falls into.

MediPharm Labs EV-to-EBIT Calculation

MediPharm Labs's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	12.842	/	-9.966
	=	-1.29

MediPharm Labs's current Enterprise Value is $12.84 Mil.
MediPharm Labs's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.97 Mil.

MediPharm Labs (OTCPK:MEDIF) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

MediPharm Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2024 )	=	EBIT	/	Enterprise Value (Q: Mar. 2024 )
	=	-9.966	/	14.5948968
	=	-68.28 %

MediPharm Labs's Enterprise Value for the quarter that ended in Mar. 2024 was $14.59 Mil.
MediPharm Labs's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-9.97 Mil.

MediPharm Labs EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of MediPharm Labs's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

MediPharm Labs (MediPharm Labs) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » MediPharm Labs Corp (OTCPK:MEDIF) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

MLZ:Germany LABS:Canada

Address

151 John Street, Barrie, ON, CAN, L4N 2L1

Website

https://www.medipharmlabs.com

MediPharm Labs Corp is a pharmaceutical company specializing in precision-based cannabinoids. The Company operates in one reportable segment, the production and sales of cannabis extracts and derivative products. Through its wholesale and white-label platforms, MediPharm Labs formulates, develops, processes, packages, and distributes cannabis extracts and cannabinoid-based products to domestic and international markets. Geographically company has a presence in Canada, Australia, Germany, and other countries and the majority of revenue derives from Canada.